Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
Kevin J Hamblett, Peter D Senter, Dana F Chace, et al.
Bioconjugate Chemistry
|
March 16, 2006
Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT)
Ralph F Alderson, Brian E Toki, Martin Roberge, et al.
Molecular Cancer Therapeutics
|
December 8, 2020
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models
Philip N Moquist, Tim D Bovee, Andrew B Waight, et al.
Nature Biotechnology
|
May 29, 2019
A coiled-coil masking domain for selective activation of therapeutic antibodies
Vivian H Trang, Xinqun Zhang, Roma C Yumul, et al.
Cancer Research
|
November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo
Dowdy Jackson, John Gooya, Shenlan Mao, et al.
The Journal of Biological Chemistry
|
February 18, 2006
Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates
May S Kung Sutherland, Russell J Sanderson, Kristine A Gordon, et al.
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A Pollack, Enrique Alvarez, Kam Fai Tse, et al.
Chemmedchem
|
December 28, 2020
Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation
Joseph Z Hamilton, Thomas A Pires, Jamie A Mitchell, et al.
Molecular Cancer Therapeutics
|
January 8, 2017
Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates
Patrick J Burke, Joseph Z Hamilton, Scott C Jeffrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2013
Development of orally active inhibitors of protein and cellular fucosylation
Nicole M Okeley, Stephen C Alley, Martha E Anderson, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 27, 2004
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate
Kevin J Hamblett, Peter D Senter, Dana F Chace, et al.
Bioconjugate Chemistry
|
March 16, 2006
Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT)
Ralph F Alderson, Brian E Toki, Martin Roberge, et al.
Molecular Cancer Therapeutics
|
December 8, 2020
Novel Auristatins with High Bystander and Cytotoxic Activities in Drug Efflux-positive Tumor Models
Philip N Moquist, Tim D Bovee, Andrew B Waight, et al.
Nature Biotechnology
|
May 29, 2019
A coiled-coil masking domain for selective activation of therapeutic antibodies
Vivian H Trang, Xinqun Zhang, Roma C Yumul, et al.
Cancer Research
|
November 18, 2008
A human antibody-drug conjugate targeting EphA2 inhibits tumor growth in vivo
Dowdy Jackson, John Gooya, Shenlan Mao, et al.
The Journal of Biological Chemistry
|
February 18, 2006
Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates
May S Kung Sutherland, Russell J Sanderson, Kristine A Gordon, et al.
Cancer Chemotherapy and Pharmacology
|
June 2, 2007
Treatment parameters modulating regression of human melanoma xenografts by an antibody-drug conjugate (CR011-vcMMAE) targeting GPNMB
Vincent A Pollack, Enrique Alvarez, Kam Fai Tse, et al.
Chemmedchem
|
December 28, 2020
Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation
Joseph Z Hamilton, Thomas A Pires, Jamie A Mitchell, et al.
Molecular Cancer Therapeutics
|
January 8, 2017
Optimization of a PEGylated Glucuronide-Monomethylauristatin E Linker for Antibody-Drug Conjugates
Patrick J Burke, Joseph Z Hamilton, Scott C Jeffrey, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 16, 2013
Development of orally active inhibitors of protein and cellular fucosylation
Nicole M Okeley, Stephen C Alley, Martha E Anderson, et al.
Page
of 9